Without any major events, it's pretty obvious where it is going to come from -- the same place it has come from for the past decade. That's not necessarily a bad thing.
They don't have anything to prove I guess. Or maybe another stupid huge buyout by a big company of this useless ad network, and that's why no PR.
I did forget to mention BARDA, but don't see any positive surprises in the short term on it.
I did mention Japan though.
I kind of mentioned China. (Lorem Vascular)
Wonder what happened to our old pal ceeing. Maybe new ID.
I've been following PPHM on and off ever since the independent trial result mix-up/fiasco. Would you say PPHM's drug line-up is more than marginal at present? In other words does it actually massively improve odds for specific cancers or is it like a "2 month extension" of life?